Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Transfer factor as an option for managing the covid-19 pandemic

D. Viza, G. Pizza, C. De Vinci, G. Brandi, D. Ablashi

. 2020 ; 66 (3) : 86-90. [pub] -

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20017803

Covid-19 or SARS-CoV-2, a new RNA virus with high infectivity, and seemingly low mutability, which appeared in 2019 in the Wuhan province of China, has created a pandemic with dire consequences. At the end of May 2020, it became the first cause of mortality. As no treatment or vaccine may become available before many months, and because occurrence of similar pandemics is only a matter of time, arguments are presented here for testing the effect of transfer factor (TF), an immunomodulator devoid of toxicity, which has been extensively studied in the past for the treatment and prevention of viral infections.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20017803
003      
CZ-PrNML
005      
20210106110351.0
007      
ta
008      
201110s2020 xr f 000 0|eng||
009      
AR
024    __
$a 10.14712/fb2020066030086 $2 doi
035    __
$a (PubMed)33069187
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Viza, D. $u Immunobiology Laboratory, Faculté de Médicine, Paris 6, France
245    10
$a Transfer factor as an option for managing the covid-19 pandemic / $c D. Viza, G. Pizza, C. De Vinci, G. Brandi, D. Ablashi
520    9_
$a Covid-19 or SARS-CoV-2, a new RNA virus with high infectivity, and seemingly low mutability, which appeared in 2019 in the Wuhan province of China, has created a pandemic with dire consequences. At the end of May 2020, it became the first cause of mortality. As no treatment or vaccine may become available before many months, and because occurrence of similar pandemics is only a matter of time, arguments are presented here for testing the effect of transfer factor (TF), an immunomodulator devoid of toxicity, which has been extensively studied in the past for the treatment and prevention of viral infections.
650    _2
$a adjuvancia imunologická $x terapeutické užití $7 D000276
650    _2
$a zvířata $7 D000818
650    _2
$a Betacoronavirus $7 D000073640
650    _2
$a koronavirové infekce $x imunologie $x terapie $7 D018352
650    _2
$a lidé $7 D006801
650    _2
$a pandemie $7 D058873
650    _2
$a virová pneumonie $x imunologie $x terapie $7 D011024
650    _2
$a výzkumný projekt $7 D012107
650    _2
$a transfer faktor $x terapeutické užití $7 D014165
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Pizza, G. $u Immunotherapy dept., S. Orsola-Malpighi University Hospital, Bologna, Italy
700    1_
$a De Vinci, C. $u Immunotherapy dept., S. Orsola-Malpighi University Hospital, Bologna, Italy
700    1_
$a Brandi, G. $u Medical Oncology, S. Orsola-Malpighi University Hospital, Bologna, Italy
700    1_
$a Ablashi, D. $u HHV-6 Foundation, Santa Barbara, CA, USA
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 66, č. 3 (2020), s. 86-90
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33069187 $y Pubmed
856    41
$u https://fb.cuni.cz/file/5926/fb2020a0012.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y p $z 0
990    __
$a 20201110 $b ABA008
991    __
$a 20210105134434 $b ABA008
999    __
$a ok $b bmc $g 1604843 $s 1107995
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 66 $c 3 $d 86-90 $e - $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
LZP    __
$b NLK138 $a Pubmed-20201110

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace